Precision Optics PE ratio POCI
Share price divided by earnings per share over the last twelve months, since 2012.
- Today, Oct 23, 2026
- n/m
- losses over the last year
- Last meaningful
- 60.9×
- Sep 2023
- Peer median
- 12.8×
Precision Optics has no meaningful PE ratio today: it lost $0.46 a share over the last twelve months, and a PE needs earnings.
It was last meaningful in Sep 2023, at 60.9×.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2023 | 60.9× | 42.0× | 68.8× |
| 2022 | n/m a value too high to mean anything | ||
| 2021 | n/m a value too high to mean anything | ||
| 2020 | n/m a value too high to mean anything | ||
| 2019 | n/m a value too high to mean anything | ||
| 2018 | n/m a value too high to mean anything | ||
| 2017 | n/m a value too high to mean anything | ||
| 2016 | n/m a value too high to mean anything | ||
| 2015 | n/m a value too high to mean anything | ||
| 2014 | n/m a value too high to mean anything | ||
| 2013 | n/m a value too high to mean anything | ||
| 2012 | 11.9× | 11.9× | 11.9× |
Against its peers
Companies in Healthcare nearest Precision Optics' size, closest first, today.
| Company | PE ratio |
|---|---|
| POCIPrecision Optics | n/m |
| ATNMActinium Pharmaceuticals | 4.2× |
| APTAlpha Pro Tech | 13.6× |
| NEPHNephros | 22.1× |
| SPROSpero Therapeutics | 10.1× |
| LFVNLifevantage | 14.7× |
| ICCCImmucell | 128× |
| KEQUKewaunee Scientific | 11.9× |
| PDEXPro DEX | 15.1× |
| PLXProtalix BioTherapeutics | 11.1× |
| NATRNatures Sunshine Products | 12.0× |
| Peer median | 12.8× |
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Precision Optics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.